Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia
Authors:
- 10 December 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 103, 108435
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19International Immunopharmacology, 2021
- Prognostic value of neutrophil‐to‐lymphocyte ratio in COVID‐19 patients: A systematic review and meta‐analysisInternational Journal Of Clinical Practice, 2021
- Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysisPLOS ONE, 2021
- Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patientsPLOS ONE, 2021
- Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19The American Journal of Emergency Medicine, 2021
- The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective StudyIn Vivo, 2021
- Controlling Cytokine Storm Is Vital in COVID-19Frontiers in Immunology, 2020
- Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19Journal of Clinical Medicine Research, 2020
- Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implicationsTherapeutic Advances in Respiratory Disease, 2020
- The Role of Interleukin 6 During Viral InfectionsFrontiers in Microbiology, 2019